Memphasys Limited (MEM) | BULLS N' BEARS

Hoof on the till: Peters backs Optiscan med-tech

Bob Peters is used to backing winners – in fact he has bred and owned a great many of them on his way to becoming the king of WA horse...

Memphasys to reinvest tax refund in the next generation

Australian-based reproductive biotechnology company, Memphasys says it has received a research and development (R&D) tax refund of about...

Memphasys brings Indian baby dreams alive with Felix

Just when all looked lost for a group of parent hopefuls in India, a groundbreaking piece of Australian medical technology developed by...

Memphasys franks Japan deal with first Felix order

Just a week into its pivotal deal with global IVF provider Vitrolife, reproductive biotechnology company Memphasys has already received...

Memphasys inks deal with global IVF provider Vitrolife

Sydney-based reproductive technology specialist Memphasys has inked an exclusive five-year distribution deal with Vitrolife Japan KK – a...

Memphasys locks in new patents for flagship IVF treatment

Memphasys goes to top of global sperm separation class

Reproductive biotechnology company Memphasys has received a boost for its flagship Felix system, with the first global study of its kind...

ASX: MEM - Memphasys

It’s a boy! A remarkable feat for a biotech – a living breathing baby is born